Viking Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Go back to Viking Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Viking Therapeutics (VKTX) Misses Q2 EPS by 2c

July 27, 2022 4:55 PM EDT

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.23), $0.02 worse than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

... More